When People with Type-1 Diabetes become adults Diabetes Technology and Transition - do we need new Models?

被引:2
|
作者
Datz, Nicolin [1 ]
Kordonouri, Olga [1 ,2 ]
Danne, Thomas [1 ,2 ]
机构
[1] Kinder & Jugendkrankenhaus BULT Hannover, Abt Kinder & Jugendmed 3, Hannover, Germany
[2] Hannover Med Sch, Hannover, Germany
关键词
D O I
10.1055/a-1332-4603
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Approximately 40 % of adolescents with type 1 diabetes lose contact with specialty care at transfer to adult care, with a marked increase in risk for poor outcomes. Adolescents showed a 2,5-fold increased risk of an HbA1c level > 9 % after transfer, compared with adolescents who remained in pediatric care. While the use of modern technologies is rapidly increasing in pediatric diabetology, fewer resources are available to address the rapidly changing digital transformation of type 1 diabetes therapy in adult diabetology, not least because of the large number of patients with type 2 diabetes who require care. Therefore, in the transition from children with type 1 diabetes to adult medicine, disparities in resource provision for training and interpretation of new diabetes technologies now add to the problems that have been known for many years. One possible solution would be the creation of regional treatment centers with pediatric and internal medicine care for people with intensive diabetes therapy and use of diabetes technology, as well as the use of telemedicine capabilities. International comparisons show that in centers where pediatric and internal medicine diabetes teams provide age-appropriate care within the same treatment facility, the transition is much less complicated and people with type 1 diabetes benefit from shared experience in the use of diabetes technologies across the lifespan. However, the implementation of such concepts under the framework of the German health care system requires a rethinking among the involved stakeholders and does not seem promising without pressure from the affected people with type 1 diabetes. Thieme. All rights reserved.
引用
收藏
页码:1200 / 1205
页数:6
相关论文
共 50 条
  • [21] Use of Telemedicine in Adults with Type 1 Diabetes: Do Age and Use of Diabetes-Related Technology Matter?
    Toschi, Elena
    Adam, Atif
    Atakov-Castillo, Astrid
    Slyne, Christine
    Laffel, Lori
    Munshi, Medha
    TELEMEDICINE AND E-HEALTH, 2023, 29 (09) : 1374 - 1382
  • [22] Long-term complications of type 1 diabetes: what do we know and what do we need to understand?
    Piona, Claudia
    Ventrici, Claudia
    Marcovecchio, Loredana
    Chiarelli, Francesco
    Maffeis, Claudio
    Bonfanti, Riccardo
    Rabbone, Ivana
    MINERVA PEDIATRICS, 2021, 73 (06): : 504 - 522
  • [23] Emotional dysfunction associated with diabetes in Mexican adolescents and young adults with type-1 diabetes
    Lerman-Garber, I
    Barrón-Uribe, C
    Calzada-León, R
    Mercado-Atri, M
    Vidal-Tamayo, R
    Quintana, S
    Hernández, ME
    Ruiz-Reyes, MDL
    Tamez-Gutiérrez, LE
    Nishimura-Meguro, E
    Villa, AR
    SALUD PUBLICA DE MEXICO, 2003, 45 (01): : 13 - 18
  • [24] Diabetes Mellitus Type 1, Latent Autoimmune Diabetes of Adults and Hepatitis C Virus: What we Know and what we Need to Know
    Tosone, Grazia
    Maraolo, Alberto Enrico
    Palmiero, Giulia
    Mascolo, Silvia
    Orlando, Raffaele
    JOURNAL OF DIABETES & METABOLISM, 2014, 5 (01)
  • [25] Diabetes Mellitus Type 1, Latent Autoimmune Diabetes of Adults and Hepatitis C Virus: What we Know and what we Need to Know
    Tosone, Grazia
    Maraolo, Alberto Enrico
    Palmiero, Giulia
    Mascolo, Silvia
    Orlando, Raffaele
    JOURNAL OF DIABETES & METABOLISM, 2014, 5
  • [26] Diabetes Mellitus Type 1, Latent Autoimmune Diabetes of Adults and Hepatitis C Virus: What we Know and what we Need to Know
    Tosone, Grazia
    Maraolo, Alberto Enrico
    Palmiero, Giulia
    Mascolo, Silvia
    Orlando, Raffaele
    JOURNAL OF DIABETES & METABOLISM, 2013, 4 (09)
  • [27] Pioglitazone-Do we really need it to manage type 2 diabetes?
    Sinha, Binayak
    Ghosal, Samit
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2013, 7 (01) : 52 - 55
  • [28] Do We Need Another Guideline on Managing Type 2 Diabetes in India?
    Gangadhar, Prathosh
    Palikhe, Gaurav
    CLINICAL DIABETOLOGY, 2023, 12 (01): : 4 - 5
  • [29] Comment and response to: dapagliflozin - do we need it registered for type 2 diabetes?
    Jabbour, Serge
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (18) : 2751 - 2752
  • [30] THE IMPACT OF SOCIOECONOMIC DEPRIVATION ON ACCESS TO DIABETES TECHNOLOGY IN ADULTS WITH TYPE 1 DIABETES
    Fallon, C.
    Jones, E.
    Oliver, N.
    Reddy, M.
    Avari, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A212 - A212